Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Structure and assembly of the Ebola virus nucleocapsid.

Wan W, Kolesnikova L, Clarke M, Koehler A, Noda T, Becker S, Briggs JAG.

Nature. 2017 Nov 16;551(7680):394-397. doi: 10.1038/nature24490. Epub 2017 Nov 8.

PMID:
29144446
2.

Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor.

Kondoh T, Manzoor R, Nao N, Maruyama J, Furuyama W, Miyamoto H, Shigeno A, Kuroda M, Matsuno K, Fujikura D, Kajihara M, Yoshida R, Igarashi M, Takada A.

PLoS One. 2017 Oct 17;12(10):e0186450. doi: 10.1371/journal.pone.0186450. eCollection 2017.

3.

The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.

Bharaj P, Atkins C, Luthra P, Giraldo MI, Dawes BE, Miorin L, Johnson JR, Krogan NJ, Basler CF, Freiberg AN, Rajsbaum R.

J Virol. 2017 Aug 24;91(18). pii: e00833-17. doi: 10.1128/JVI.00833-17. Print 2017 Sep 15.

PMID:
28679761
4.

The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.

Dilley KA, Voorhies AA, Luthra P, Puri V, Stockwell TB, Lorenzi H, Basler CF, Shabman RS.

PLoS One. 2017 Jun 21;12(6):e0178717. doi: 10.1371/journal.pone.0178717. eCollection 2017.

5.
6.

Investigating Engineered Ribonucleoprotein Particles to Improve Oral RNAi Delivery in Crop Insect Pests.

Gillet FX, Garcia RA, Macedo LLP, Albuquerque EVS, Silva MCM, Grossi-de-Sa MF.

Front Physiol. 2017 Apr 28;8:256. doi: 10.3389/fphys.2017.00256. eCollection 2017.

7.

Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.

Luthra P, Aguirre S, Yen BC, Pietzsch CA, Sanchez-Aparicio MT, Tigabu B, Morlock LK, García-Sastre A, Leung DW, Williams NS, Fernandez-Sesma A, Bukreyev A, Basler CF.

MBio. 2017 Apr 4;8(2). pii: e00368-17. doi: 10.1128/mBio.00368-17.

8.

Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.

Olejnik J, Forero A, Deflubé LR, Hume AJ, Manhart WA, Nishida A, Marzi A, Katze MG, Ebihara H, Rasmussen AL, Mühlberger E.

J Virol. 2017 May 12;91(11). pii: e00179-17. doi: 10.1128/JVI.00179-17. Print 2017 Jun 1.

9.

Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity.

Liu Y, Olagnier D, Lin R.

Front Immunol. 2017 Jan 3;7:662. doi: 10.3389/fimmu.2016.00662. eCollection 2016. Review.

10.

Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.

Bruhn JF, Kirchdoerfer RN, Urata SM, Li S, Tickle IJ, Bricogne G, Saphire EO.

J Virol. 2017 Jan 3;91(2). pii: e01085-16. doi: 10.1128/JVI.01085-16. Print 2017 Jan 15.

11.
12.

Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA.

Thi EP, Lee AC, Geisbert JB, Ursic-Bedoya R, Agans KN, Robbins M, Deer DJ, Fenton KA, Kondratowicz AS, MacLachlan I, Geisbert TW, Mire CE.

Nat Microbiol. 2016 Aug 22;1(10):16142. doi: 10.1038/nmicrobiol.2016.142.

13.

In silico and in vitro methods to identify ebola virus VP35-dsRNA inhibitors.

Glanzer JG, Byrne BM, McCoy AM, James BJ, Frank JD, Oakley GG.

Bioorg Med Chem. 2016 Nov 1;24(21):5388-5392. doi: 10.1016/j.bmc.2016.08.065. Epub 2016 Sep 4.

14.

RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription.

Biedenkopf N, Schlereth J, Grünweller A, Becker S, Hartmann RK.

J Virol. 2016 Jul 27;90(16):7481-96. doi: 10.1128/JVI.00271-16. Print 2016 Aug 15.

15.

Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions.

Nelson EV, Schmidt KM, Deflubé LR, Doğanay S, Banadyga L, Olejnik J, Hume AJ, Ryabchikova E, Ebihara H, Kedersha N, Ha T, Mühlberger E.

J Virol. 2016 Jul 27;90(16):7268-84. doi: 10.1128/JVI.00459-16. Print 2016 Aug 15.

16.

Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis.

Banadyga L, Dolan MA, Ebihara H.

J Mol Biol. 2016 Aug 28;428(17):3449-66. doi: 10.1016/j.jmb.2016.05.008. Epub 2016 May 14. Review.

17.

Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.

Yen BC, Basler CF.

J Virol. 2016 Apr 29;90(10):5108-18. doi: 10.1128/JVI.00191-16. Print 2016 May 15.

18.

When your cap matters: structural insights into self vs non-self recognition of 5' RNA by immunomodulatory host proteins.

Leung DW, Amarasinghe GK.

Curr Opin Struct Biol. 2016 Feb;36:133-41. doi: 10.1016/j.sbi.2016.02.001. Epub 2016 Feb 23. Review.

19.

Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.

Edwards MR, Liu G, Mire CE, Sureshchandra S, Luthra P, Yen B, Shabman RS, Leung DW, Messaoudi I, Geisbert TW, Amarasinghe GK, Basler CF.

Cell Rep. 2016 Feb 23;14(7):1632-1640. doi: 10.1016/j.celrep.2016.01.049. Epub 2016 Feb 11.

20.

Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus.

Messaoudi I, Amarasinghe GK, Basler CF.

Nat Rev Microbiol. 2015 Nov;13(11):663-76. doi: 10.1038/nrmicro3524. Epub 2015 Oct 6. Review.

Supplemental Content

Support Center